IT202100003899A1 - Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention - Google Patents
Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention Download PDFInfo
- Publication number
- IT202100003899A1 IT202100003899A1 IT102021000003899A IT202100003899A IT202100003899A1 IT 202100003899 A1 IT202100003899 A1 IT 202100003899A1 IT 102021000003899 A IT102021000003899 A IT 102021000003899A IT 202100003899 A IT202100003899 A IT 202100003899A IT 202100003899 A1 IT202100003899 A1 IT 202100003899A1
- Authority
- IT
- Italy
- Prior art keywords
- hair
- alopecia
- nutri
- food supplement
- cosmetic treatment
- Prior art date
Links
- 201000004384 Alopecia Diseases 0.000 title claims description 32
- 235000015872 dietary supplement Nutrition 0.000 title claims description 14
- 231100000360 alopecia Toxicity 0.000 title claims description 13
- 238000011282 treatment Methods 0.000 title claims description 12
- 230000002265 prevention Effects 0.000 title claims description 8
- 230000002526 effect on cardiovascular system Effects 0.000 title claims description 7
- 239000002537 cosmetic Substances 0.000 title claims description 6
- 239000000284 extract Substances 0.000 claims description 17
- 240000008397 Ganoderma lucidum Species 0.000 claims description 13
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 230000009286 beneficial effect Effects 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 235000013325 dietary fiber Nutrition 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 description 18
- 230000003676 hair loss Effects 0.000 description 16
- 208000024963 hair loss Diseases 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 208000004631 alopecia areata Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000008092 positive effect Effects 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 206010068168 androgenetic alopecia Diseases 0.000 description 3
- 201000002996 androgenic alopecia Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000003659 hair regrowth Effects 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- XFZJEEAOWLFHDH-NFJBMHMQSA-N procyanidin B2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N Folic acid Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010048886 Onychoclasis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 229920002350 Procyanidin B2 Polymers 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002137 ergosterols Chemical class 0.000 description 1
- 235000021112 essential micronutrients Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000003806 hair structure Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000001297 telogen effluvium Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Description
Descrizione dell?invenzione Industriale avente per titolo: Description of the industrial invention having the title:
?INTEGRATORE ALIMENTARE PER IL TRATTAMENTO NUTRI-COSMETICO DELL?ALOPECIA E LA PREVENZIONE CARDIOVASCOLARE? ?DIETARY SUPPLEMENT FOR THE NUTRI-COSMETIC TREATMENT OF ALOPECIA AND CARDIOVASCULAR PREVENTION?
DESCRIZIONE DESCRIPTION
La presente invenzione si inserisce nel settore tecnologico degli integratori alimentari. In particolare si riferisce ad un integratore alimentare per il trattamento nutri-cosmetico dell?alopecia e la prevenzione cardiovascolare, con effetti positivi sulla vitalit? generale dell?organismo. The present invention fits into the technological sector of food supplements. In particular, it refers to a food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention, with positive effects on the vitality of the hair. general of? organism.
Gli integratori alimentari sono alimenti presentati in piccole unit? di consumo come capsule, compresse, fialoidi e simili. Si caratterizzano come fonti concentrate di nutrienti o altre sostanze ad effetto ?fisiologico? che non hanno una finalit? di cura, prerogativa esclusiva dei farmaci, perch? sono ideati e proposti per favorire nell?organismo il regolare svolgimento di specifiche funzioni o la normalit? di specifici parametri funzionali o per ridurre i fattori di rischio di malattie. Food supplements are foods presented in small units. consumables such as capsules, tablets, vials and the like. They are characterized as concentrated sources of nutrients or other substances with a ?physiological? effect? that have no purpose? of care, the exclusive prerogative of drugs, why? are designed and proposed to promote the regular performance of specific functions in the body or normality? of specific functional parameters or to reduce disease risk factors.
Un settore in cui gli integratori alimentari possono avere un effetto benefico ? nel trattamento nutri-cosmetico dell?alopecia, nella prevenzione cardiovascolare e azione nella vitalit? generale dell?organismo. An area where dietary supplements can have a beneficial effect? in the nutri-cosmetic treatment of alopecia, in cardiovascular prevention and action in the vitality? general of? organism.
In particolare, per quanto concerne l?alopecia, la perdita durante la giornata di un certo numero di capelli (50?100) rappresenta un evento del tutto naturale. In alcune condizioni per? questo fenomeno pu? aumentare fino a determinare un diradamento progressivo della capigliatura. In particular, as far as alopecia is concerned, the loss of a certain number of hairs (50?100) during the day represents a completely natural event. Under some conditions for? this phenomenon can increase to determine a progressive thinning of the hair.
Numerose sono le cause che possono portare alla caduta dei capelli, ad esempio: There are many causes that can lead to hair loss, for example:
- i trattamenti tricologici aggressivi quali la tintura dei capelli, l?arricciatura, la permanente; - la presenza di patologie quali le anemie, la psoriasi, la vitiligine, l?alopecia, la dermatite seborroica; - aggressive trichological treatments such as hair dyeing, curling, perms; - the presence of pathologies such as anemia, psoriasis, vitiligo, alopecia, seborrheic dermatitis;
- le disfunzioni ormonali quali le malattie della tiroide, la sindrome dell?ovaio policistico, il diabete; - hormonal dysfunctions such as thyroid disease, polycystic ovary syndrome, diabetes;
- l?alimentazione scorretta dovuta a diete dimagranti drastiche, carenza di vitamina D, ferro, rame e zinco; - incorrect nutrition due to drastic slimming diets, lack of vitamin D, iron, copper and zinc;
- le terapie farmacologiche come i farmaci per ridurre il colesterolo, i cortisonici, i diuretici, i chemioterapici; - pharmacological therapies such as drugs to reduce cholesterol, cortisone, diuretics, chemotherapy;
- lo stress psicofisico; - psychophysical stress;
- la predisposizione genetica. - genetic predisposition.
La caduta dei capelli interessa principalmente gli uomini (circa il 60%). Generalmente esordisce molto lentamente, talvolta associandosi all?aumento della produzione del sebo e alla presenza di forfora, ed ? tanto pi? precoce e grave quanti pi? membri della famiglia ne sono affetti. Hair loss mainly affects men (about 60%). It generally begins very slowly, sometimes associated with increased sebum production and the presence of dandruff, and is all the more precocious and serious how much more? family members are affected.
La causa principale della caduta dei capelli nell?uomo ? rappresentata dall?alopecia androgenetica (o calvizie comune) cos? chiamata perch? a provocarla sono soprattutto due fattori, ovvero gli ormoni androgeni e l?eredit?. The main cause of hair loss in men? represented by androgenetic alopecia (or common baldness) cos? call why? it is mainly caused by two factors, namely androgen hormones and heredity.
Questo tipo di alopecia non dipende da un eccesso di ormoni androgeni, ma da una maggiore sensibilit? del capello ad essi. Gli uomini affetti da calvizie, infatti, non hanno livelli di androgeni nel sangue pi? elevati rispetto loro coetanei con i capelli, ma semplicemente sono pi? sensibili agli effetti che questi ormoni provocano a livello del follicolo del pelo. This type of alopecia does not depend on an excess of androgen hormones, but on a greater sensitivity? of the hair to them. In fact, men suffering from baldness do not have androgen levels in their blood more than normal. higher than their peers with hair, but are simply more? sensitive to the effects that these hormones cause at the level of the hair follicle.
Nelle donne la caduta dei capelli ? meno diffusa rispetto agli uomini. Di norma i capelli femminili sono pi? spessi, resistenti e manifestano una crescita pi? rapida e prolungata rispetto a quelli maschili. Hair loss in women? less common than in men. As a rule, female hair is more? thick, resistant and show a faster growth? rapid and prolonged than those for men.
Nelle donne la causa principale di caduta dei capelli ? da ricercarsi negli squilibri ormonali. La menopausa, ad esempio, rappresenta una fase molto importante e delicata. Durante questo periodo della vita spesso si osservano alcune modificazioni morfologiche a carico dei capelli che tendono ad assottigliarsi e a diradarsi moderatamente. Dopo la menopausa il 50% delle donne presenta infatti una rarefazione dei capelli. The main cause of hair loss in women? to be found in hormonal imbalances. Menopause, for example, represents a very important and delicate phase. During this period of life, some morphological changes are often observed in the hair which tends to thin and moderately thin out. After menopause, 50% of women have thinning hair.
Tra le forme di perdita dei capelli che interessano principalmente le donne, ma che si riscontra anche negli uomini, vi ? la cosiddetta perdita diffusa, detta anche telogen effluvium, che interessa l?intero cuoio capelluto e che, nelle fasi iniziali, pu? risultare impercettibile. Generalmente insorge dopo episodi ?importanti? quali febbre, parto o interventi chirurgici, dura in media 2?3 mesi e, sebbene il recupero sia lento, il cuoio capelluto pu? tornare alla normalit?. Among the forms of hair loss that mainly affect women, but which is also found in men, there is? the so-called diffuse loss, also called telogen effluvium, which affects the entire scalp and which, in the initial stages, can be imperceptible. It usually arises after ?important? such as fever, childbirth or surgery, it lasts an average of 2-3 months and, although recovery is slow, the scalp can? return to normal?.
Negli ultimi anni sembrano essere in aumento i casi di alopecia femminile che insorgono in et? precoce, dovuti probabilmente allo stress psicofisico e ad altre cause ambientali che influenzano direttamente o indirettamente l?equilibrio ormonale. In recent years there seems to be an increase in cases of female alopecia that arise in the age of early, probably due to psychophysical stress and other environmental causes that directly or indirectly influence the hormonal balance.
Nelle donne, generalmente, la caduta dei capelli segue una dinamica diversa rispetto agli uomini: ? pi? tardiva, ha un?evoluzione pi? lenta e interessa dapprima il vertice della testa e poi le altre zone del cuoio capelluto. In women, hair loss generally follows a different dynamic than in men: ? more late, has a? evolution pi? slow and first affects the vertex of the head and then the other areas of the scalp.
Una forma di caduta di capelli che si pu? riscontrare con uguale frequenza sia nell?uomo sia nella donna ? l?alopecia areata, cos? chiamata poich? la perdita dei capelli determina in breve tempo la formazione di zone calve di forma rotondeggiante di varie dimensioni. Spesso esordisce prima della maturit? e si pu? manifestare in qualunque parte del cuoio capelluto, oltre che a livello di ascelle e pube; nell?uomo pu? presentarsi anche sulla barba. One form of hair loss that can occur? found with equal frequency in both men and women? alopecia areata, cos? call because? hair loss causes in a short time the formation of round bald patches of various sizes. Often begins before maturity and can you? manifest in any part of the scalp, as well as in the armpits and pubis; in? man can? also show up on the beard.
Nella maggior parte dei casi i capelli che cadono a causa dell?alopecia areata ricrescono spontaneamente, ma la malattia pu? recidivare. Si riscontra principalmente nei giovani adulti, mentre ? rara al di sopra dei 60 anni. Per quanto riguarda le cause, l?alopecia areata ? considerata ormai con certezza una malattia su base autoimmune con una complessa componente di trasmissione genetica su cui intervengono anche altri fattori come lo stress psicofisico, l?alimentazione scorretta o la presenza di malattie, soprattutto quelle su base autoimmune. In most cases, the hair that falls out due to alopecia areata grows back on its own, but the disease can reoffend. It is mainly found in young adults, while ? rare over 60 years. As for the causes, alopecia areata? now considered with certainty an autoimmune disease with a complex component of genetic transmission on which other factors also intervene such as psychophysical stress, incorrect nutrition or the presence of diseases, especially those on an autoimmune basis.
L?utilizzo con costanza di prodotti specifici pu? rappresentare un valido supporto per contrastare la caduta dei capelli. The constant use of specific products can? represent a valid support to counteract hair loss.
Le cause di cui sopra vengono normalmente contrastate mediante l?uso di integratori alimentari che forniscono all?organismo nutrienti o altre sostanze ad effetto ?fisiologico?. The above causes are normally contrasted through the use of food supplements which supply the body with nutrients or other substances with a ?physiological? effect.
L?uso degli integratori, infatti, rende forti e sani tutti gli annessi cutanei, come capelli e unghie. Per ottenere questo effetto devono contenere particolari principi attivi quali: In fact, the use of supplements makes all skin appendages, such as hair and nails, strong and healthy. To obtain this effect they must contain particular active ingredients such as:
- amminoacidi solforati; - sulfur amino acids;
- vitamine; - vitamins;
- minerali; - minerals;
- biotina; - biotin;
- acido pantotenico. - pantothenic acid.
La donna, in particolar modo ha bisogno di: - vitamina B12; Women especially need: - vitamin B12;
- acido folico; - folic acid;
che sono utili per prevenire la debolezza legata ad una possibile anemia. which are useful for preventing weakness related to possible anemia.
Infine vi ? il gruppo delle vitamine antiossidanti. Finally there ? the group of antioxidant vitamins.
Gli integratori per capelli naturali contengono ingredienti ad azione completa, che agiscono cio? dal cuoio capelluto fino alle punte. Principalmente sono a base di: Natural hair supplements contain full-acting ingredients, which act from the scalp to the ends. They are mainly based on:
- sali minerali: il magnesio, che favorisce la circolazione sanguigna, il ferro che alimenta l'emoglobina responsabile della distribuzione dell'ossigeno nei vari tessuti, lo zinco che costituisce il 95% della struttura del capello; - mineral salts: magnesium, which promotes blood circulation, iron which feeds the hemoglobin responsible for the distribution of oxygen in the various tissues, zinc which makes up 95% of the hair structure;
- vitamine E, C: ristrutturano il capello e lo rinforzano, rendendolo lucido e dall'aspetto sano; - antiossidanti: contrastano la caduta del capello e l'invecchiamento; - vitamins E, C: restructure the hair and strengthen it, making it shiny and healthy-looking; - antioxidants: counteract hair loss and ageing;
- aminoacidi: essenziali per le proteine che aiutano la crescita del capello e responsabili della salute del bulbo del capello. - amino acids: essential for the proteins that help hair growth and are responsible for the health of the hair bulb.
Generalmente gli integratori devono essere assunti per un periodo che varia tra i due e i tre mesi e il trattamento deve essere associato ad una corretta dieta alimentare, in quanto il problema della caduta di capelli unitamente a quelli di unghia fragili pu? riflettere una carenza di determinate vitamine nell?organismo, non metabolizzate dalla dieta. Generally the supplements must be taken for a period that varies between two and three months and the treatment must be associated with a correct diet, as the problem of hair loss together with those of brittle nails can lead to problems. reflect a lack of certain vitamins in the body, not metabolized by the diet.
Scopo della presente invenzione ? quello di fornire un integratore alimentare, con nuovi ingredienti, che presenti un particolare effetto positivo nell?organismo, principalmente nel trattamento nutri-cosmetico dell?alopecia, ma anche nella prevenzione cardiovascolare e con una significativa azione benefica generale sull?organismo, con un significativo aumento dell?efficacia rispetto agli integratori attuali. Purpose of the present invention? that of providing a food supplement, with new ingredients, which has a particular positive effect on the body, mainly in the nutri-cosmetic treatment of alopecia, but also in cardiovascular prevention and with a significant general beneficial action on the body, with a significant increased effectiveness compared to current supplements.
Quello descritto e altri scopi, come verr? esplicitato nel seguito, vengono raggiunti con un formulato conforme alla rivendicazione 1. The one described and other purposes, how will it come? explained below, are achieved with a formulation in accordance with claim 1.
La composizione secondo l?invenzione ? un integratore alimentare per il trattamento nutricosmetico dell?alopecia, con effetti benefici nella prevenzione cardiovascolare e sull?organismo. Detto integratore ? composto al 100% da prodotti naturali ed ? caratterizzato dal fatto di avere la seguente composizione: The composition according to the invention? a food supplement for the nutricosmetic treatment of alopecia, with beneficial effects in cardiovascular prevention and on the body. Said supplement? composed of 100% natural products and ? characterized by the fact that it has the following composition:
- estratto secco di melannurca 0,8 g - estratto secco di Ganoderma lucidum 1 g - fibra alimentare solubile (maltodextrina) 7,2 g L?estratto di melannurca ? preferibilmente ricavato da una variet? di mele annurche IGP originarie delle campagne di Pozzuoli (NA), ed il Ganoderma lucidum ? un fungo molto usato nella medicina tradizionale cinese. - dry extract of melannurca 0.8 g - dry extract of Ganoderma lucidum 1 g - soluble dietary fiber (maltodextrin) 7.2 g The extract of melannurca ? preferably made from a variety? of PGI annurca apples originating from the countryside of Pozzuoli (NA), and the Ganoderma lucidum ? a mushroom widely used in traditional Chinese medicine.
Il formulato in oggetto pu? essere utilizzato anche come coadiuvante per la protezione dei capelli e il mantenimento dello stato di benessere generale. The formulation in question pu? It can also be used as an adjuvant for hair protection and maintenance of general well-being.
Resta inteso che tutte le rivendicazioni allegate formano parte integrante della presente descrizione. It is understood that all the attached claims form an integral part of the present description.
Risulter? immediatamente ovvio che si potranno apportare alla composizione descritta innumerevoli varianti e modifiche (per esempio relative a natura concentrazione e funzionalit? equivalenti) senza discostarsi dal campo di protezione dell'invenzione, come appare dalle rivendicazioni allegate. will result? it is immediately obvious that innumerable variations and modifications (for example relating to the nature, concentration and equivalent functionalities) can be made to the described composition without departing from the scope of protection of the invention, as appears from the attached claims.
La presente invenzione verr? meglio descritta da una forma preferita di attuazione, fornita a titolo esemplificativo e non limitativo. This invention will come better described by a preferred embodiment, provided by way of non-limiting example.
L?integratore alimentare per la cura dei capelli secondo l?invenzione ? composto da ingredianti, naturali al 100%, a base di estratto di mela secco di melannurca ed estratto secco di Ganoderma lucidum, un fungo molto usato nella medicina tradizionale cinese, al quale vengono attribuite numerose propriet? terapeutiche e la capacit? di curare una grande variet? di disturbi. The dietary supplement for hair care according to the invention ? composed of 100% natural ingredients, based on dry apple extract of melannurca and dry extract of Ganoderma lucidum, a mushroom widely used in traditional Chinese medicine, to which numerous properties are attributed. therapeutics and the ability? to cure a large variety? of disturbances.
Secondo una forma preferita di attuazione, l?integratore alimentare secondo l?invenzione ha la seguente composizione: According to a preferred embodiment, the food supplement according to the invention has the following composition:
- estratto secco di melannurca 0,8 g - estratto secco di Ganoderma lucidum 1 g - fibra alimentare solubile (maltodextrina) 7,2 g La forma commerciale ? preferibilmente uno stick pack da 10ml. - dry extract of melannurca 0.8 g - dry extract of Ganoderma lucidum 1 g - soluble dietary fiber (maltodextrin) 7.2 g The commercial form? preferably a 10ml stick pack.
La melannurca ? un frutto che contiene un?elevata quantit? di polifenoli, specialmente di procianidine di tipo B, responsabili di effetti positivi sulla salute. L?estratto di melannurca ha dato ottimi risultati nel trattamento nutricosmetico dell?alopecia, grazie all?abbondante quantit? di procianidina B2, tale principio attivo, ha infatti la capacit? di stimolare la ricrescita e il trofismo dei capelli sia in vitro che in vivo, promuove la fase anagen del ciclo vitale, aumenta la biosintesi di cheratina e stimola le cellule staminali della guaina esterna della radice, favorendo la riorganizzazione del follicolo. The melancholy? a fruit that contains a?high quantity? of polyphenols, especially of type B procyanidins, responsible for positive effects on health. The melannurca extract has given excellent results in the nutricosmetic treatment of alopecia, thanks to the abundant quantity of procyanidin B2, this active ingredient, has in fact the ability? to stimulate hair regrowth and trophism both in vitro and in vivo, promotes the anagen phase of the life cycle, increases the biosynthesis of keratin and stimulates the stem cells of the outer root sheath, favoring the reorganization of the follicle.
Il Ganoderma lucidum o Reishi ? un fungo che contiene un complesso di principi attivi in grado di sviluppare alcuni effetti positivi in favore del corpo e dell?organismo umano. Il Reishi contiene oltre 150 sostanze attive ad effetto benefico che ne sostengono la validit? come rimedio naturale in grado di ricoprire molteplici funzioni, ciascuna delle quali attribuibile ad ogni singolo principio attivo in esso contenuto: polisaccaridi, acido oleico, acido ganoderico e pantotenico, nucletodi, ergosteroli, proteine e peptidi. Presenta inoltre tracce di micronutrienti essenziali quali il ferro, il manganese, il rame, il potassio, il calcio e il germanio, nonch? le vitamine del gruppo B, gli aminoacidi, il glucosio, l?adenosina, il mannosio. Ganoderma lucidum or Reishi? a mushroom that contains a complex of active ingredients capable of developing some positive effects in favor of the body and the human organism. Reishi contains over 150 active substances with a beneficial effect which support its validity. as a natural remedy capable of covering multiple functions, each of which attributable to each single active ingredient contained in it: polysaccharides, oleic acid, ganoderic and pantothenic acid, nucleotides, ergosterols, proteins and peptides. It also has traces of essential micronutrients such as iron, manganese, copper, potassium, calcium and germanium, as well as? vitamins of group B, amino acids, glucose, adenosine, mannose.
L?alopecia areata ? una malattia autoimmune che causa la perdita a chiazze dei capelli. Uno studio condotto su 22 persone affette da questa patologia ha dato risultati significativi, che confermano le propriet? curative dei funghi, nella fattispecie il Ganoderma lucidum. Il 78,9% delle persone a cui ? stato somministrato il Ganoderma lucidum, ha riscontrato un beneficio, l?80% ha avuto la ricrescita dei capelli in 12 settimane. The alopecia areata ? an autoimmune disease that causes patchy hair loss. A study conducted on 22 people suffering from this pathology has given significant results, which confirm the properties healing of mushrooms, in this case the Ganoderma lucidum. 78.9% of people to whom ? was administered Ganoderma lucidum, found a benefit, 80% had hair regrowth in 12 weeks.
L?integratore nutraceutico secondo l?invenzione ? quindi un integratore alimentare 100% naturale, somministrabile per via orale, in forma farmaceutica semisolida (gel), prodotto in singole bustine predosate la cui formulazione ? composta principalmente di due estratti naturali quali: estratto secco di melannurca ed estratto di ganoderma in percentuali variabili a seconda della presenza di eccipienti o eventuali principi attivi supplementari presenti in composizioni minoritarie. The nutraceutical supplement according to the invention ? therefore a 100% natural food supplement, which can be administered orally, in semi-solid pharmaceutical form (gel), produced in single pre-measured sachets whose formulation? mainly composed of two natural extracts such as: dry extract of melannurca and ganoderma extract in variable percentages depending on the presence of excipients or any additional active ingredients present in minority compositions.
L?estratto di melannurca (sia da solo che associato ad altri componenti come zinco e selenio) dopo 60 gg di trattamento aumenta la densit?, il calibro e il contenuto di cheratina dei capelli. After 60 days of treatment, the melannurca extract (both alone and associated with other components such as zinc and selenium) increases the density, size and keratin content of the hair.
Il Ganoderma lucidum ha dimostrato risultati eccezionali nella ricrescita dei capelli; l?utilizzo costante di integratori alimentari contenenti estratto standardizzato di Reishi sembrerebbe agire sull?alopecia contrastando le conversioni dell?ormone testosterone in diidrotestosterone (DHT), quest?ultimo responsabile dell?alopecia androgenetica (AGA). La formulazione inedita dell?integratore naturale e l?azione sinergica dei due principi attivi, rappresenta un?innovazione nel settore della tricologia. Le sorgenti e le molecole selezionate come principi attivi hanno dimostrato una forte azione sinergica sia nella prevenzione che nel trattamento di patologie e disturbi legati alla salute e alla perdita del capello. Ganoderma lucidum has demonstrated outstanding results in hair regrowth; the constant use of food supplements containing standardized extract of Reishi would seem to act on alopecia by contrasting the conversions of the hormone testosterone into dihydrotestosterone (DHT), the latter responsible for androgenetic alopecia (AGA). The new formulation of the natural supplement and the synergistic action of the two active ingredients represent an innovation in the trichology sector. The sources and molecules selected as active ingredients have demonstrated a strong synergistic action both in the prevention and in the treatment of pathologies and disorders related to health and hair loss.
L?estratto di melannurca ripristina la salute e l?equilibrio sia della cute (cuoio capelluto), sia del capello, amplificando l?azione di ricrescita dell?estratto di ganoderma lucidum. The melannurca extract restores the health and balance of both the skin (scalp) and the hair, amplifying the regrowth action of the ganoderma lucidum extract.
Il formulato secondo l?invenzione garantisce quindi una ricrescita, veloce e duratura conferendo al capello tutti i nutrienti necessari al suo sviluppo e alla sua fortificazione. The formulation according to the invention therefore guarantees fast and long-lasting regrowth, giving the hair all the nutrients necessary for its development and fortification.
Si ? descritta una forma preferita di attuazione dell?invenzione, ma naturalmente essa ? suscettibile di ulteriori modifiche e varianti nell?ambito della medesima idea inventiva. In particolare, agli esperti nel ramo risulteranno immediatamente evidenti numerose varianti e modifiche, funzionalmente equivalenti alle precedenti, che ricadono nel campo di protezione dell'invenzione, come evidenziato nelle rivendicazioni allegate nelle quali i segni di riferimento posti tra parentesi non possono essere interpretati nel senso di limitare le rivendicazioni stesse. Inoltre, la parola ?comprendente? non esclude la presenza di elementi e/o fasi diversi da quelli elencati nelle rivendicazioni. L?articolo ?un?, ?uno? o ?una? precedente un elemento non esclude la presenza di una pluralit? di tali elementi. Il semplice fatto che alcune caratteristiche siano citate in rivendicazioni dipendenti diverse tra loro non indica che una combinazione di queste caratteristiche non possa essere vantaggiosamente utilizzata. Yes ? described a preferred embodiment of the invention, but of course it? susceptible to further modifications and variations within the ambit of the same inventive idea. In particular, numerous variants and modifications, functionally equivalent to the previous ones, which fall within the scope of protection of the invention, will be immediately apparent to those skilled in the art, as evidenced in the attached claims in which the reference signs placed in brackets cannot be interpreted in the sense to limit the claims themselves. Furthermore, the word ?comprising? does not exclude the presence of elements and/or phases other than those listed in the claims. The article ?un?, ?uno? or ?a? previous an element does not exclude the presence of a plurality? of such elements. The mere fact that some features are mentioned in different dependent claims does not indicate that a combination of these features cannot be used to advantage.
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000003899A IT202100003899A1 (en) | 2021-02-19 | 2021-02-19 | Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention |
BR112023016156A BR112023016156A2 (en) | 2021-02-19 | 2021-10-06 | FOOD SUPPLEMENT FOR A NUTRI-COSMETIC TREATMENT AGAINST ALOPECIA AND FOR CARDIOVASCULAR PREVENTION. |
PCT/IT2021/050319 WO2022175991A1 (en) | 2021-02-19 | 2021-10-06 | Food supplement for a nutri-cosmetic treatment of alopecia and for cardiovascular prevention |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000003899A IT202100003899A1 (en) | 2021-02-19 | 2021-02-19 | Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202100003899A1 true IT202100003899A1 (en) | 2021-05-19 |
Family
ID=75340191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102021000003899A IT202100003899A1 (en) | 2021-02-19 | 2021-02-19 | Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention |
Country Status (3)
Country | Link |
---|---|
BR (1) | BR112023016156A2 (en) |
IT (1) | IT202100003899A1 (en) |
WO (1) | WO2022175991A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1759683A1 (en) * | 2004-05-21 | 2007-03-07 | Furusatomura Development Center Co., Ltd. | Scalp and hair-care composition |
US10905723B2 (en) * | 2017-06-13 | 2021-02-02 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
-
2021
- 2021-02-19 IT IT102021000003899A patent/IT202100003899A1/en unknown
- 2021-10-06 BR BR112023016156A patent/BR112023016156A2/en unknown
- 2021-10-06 WO PCT/IT2021/050319 patent/WO2022175991A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1759683A1 (en) * | 2004-05-21 | 2007-03-07 | Furusatomura Development Center Co., Ltd. | Scalp and hair-care composition |
US10905723B2 (en) * | 2017-06-13 | 2021-02-02 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
Non-Patent Citations (4)
Title |
---|
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 2 October 2018 (2018-10-02), BADOLATI NADIA ET AL: "Annurca Apple Polyphenols Ignite Keratin Production in Hair Follicles by Inhibiting the Pentose Phosphate Pathway and Amino Acid Oxidation.", XP002804546, Database accession no. NLM30279339 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 20 November 2018 (2018-11-20), RICCIO GENNARO ET AL: "Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward [beta]-Oxidation.", XP002804545, Database accession no. NLM30463345 * |
NUTRIENTS 02 OCT 2018, vol. 10, no. 10, 2 October 2018 (2018-10-02), ISSN: 2072-6643 * |
NUTRIENTS 20 NOV 2018, vol. 10, no. 11, 20 November 2018 (2018-11-20), ISSN: 2072-6643 * |
Also Published As
Publication number | Publication date |
---|---|
WO2022175991A1 (en) | 2022-08-25 |
BR112023016156A2 (en) | 2023-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1515712B1 (en) | Use of taurine for the treatment of alopecia | |
KR100761660B1 (en) | A composition for promoting hair growth | |
EP1583509B1 (en) | Orally administrable composition for improving hair and coat quality | |
WO2011009863A1 (en) | Stevia extract or steviol for hair care | |
US20110060039A1 (en) | Composition | |
KR101141779B1 (en) | Composition for promoting hair growth comprising extract or a saponin fraction of Codonopis lanceolata | |
WO2008081142A2 (en) | Oral use of at least one monounsaturated fatty acid for hair improvement | |
KR20160008055A (en) | Composition for improving hair or skin conditions comprising Camellia japonica leaf extract | |
Khan et al. | In vivo evaluation of stable cream containing flavonoids on hydration and TEWL of human skin | |
KR20130038925A (en) | New use of hesperetin | |
IT202100003899A1 (en) | Food supplement for the nutri-cosmetic treatment of alopecia and cardiovascular prevention | |
KR101965594B1 (en) | Composition for prevention of losing hair or promotion of growing hair comprising bean extract | |
US9561224B1 (en) | Methods and compositions for treating androgenetic alopecia | |
RU2546906C1 (en) | Enriched vitaminised dragee | |
EP3256095B1 (en) | Use of a combination of taurine or a derivative thereof, biotin, vitamin c, zinc or a salt thereof and grape extract for combating fine hair | |
CN111543572A (en) | Solid beverage and preparation method thereof | |
JP2017081874A (en) | Skin moisturizer for oral ingestion or administration | |
EP1317239B1 (en) | Synergetic combinations based on plants for treating hair loss | |
KR102579306B1 (en) | Cosmetics composition for anti-alopecia | |
Faruk et al. | Hair Loss Management | |
ITMI20131792A1 (en) | USE OF A VEGETAL EXTRACT FOR THE PREVENTION AND TREATMENT OF HAIR LOSS | |
KR102488287B1 (en) | Health food containing biotin | |
WO2023084468A1 (en) | A composition for a chewable gummy for improved skin and a method thereof | |
KR20230130405A (en) | Composition for preventing hair loss or promoting hair growth comprising Aralia cordata extract | |
JPS58162511A (en) | Hair nourishing composition |